MED MATTERS LTD

Company Registration Number:
07773448 (England and Wales)

Unaudited abridged accounts for the year ended 29 September 2024

Period of accounts

Start date: 30 September 2023

End date: 29 September 2024

MED MATTERS LTD

Contents of the Financial Statements

for the Period Ended 29 September 2024

Balance sheet
Notes

MED MATTERS LTD

Balance sheet

As at 29 September 2024


Notes

2024

2023


£

£
Fixed assets
Tangible assets: 3 67,020 79,370
Total fixed assets: 67,020 79,370
Current assets
Debtors:   769,487 908,532
Cash at bank and in hand: 770 442
Total current assets: 770,257 908,974
Creditors: amounts falling due within one year:   (294,252) (455,067)
Net current assets (liabilities): 476,005 453,907
Total assets less current liabilities: 543,025 533,277
Creditors: amounts falling due after more than one year:   (184,236) (146,736)
Total net assets (liabilities): 358,789 386,541
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 358,689 386,441
Shareholders funds: 358,789 386,541

The notes form part of these financial statements

MED MATTERS LTD

Balance sheet statements

For the year ending 29 September 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 27 June 2025
and signed on behalf of the board by:

Name: Ross Tyler Burgess
Status: Director

The notes form part of these financial statements

MED MATTERS LTD

Notes to the Financial Statements

for the Period Ended 29 September 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

MED MATTERS LTD

Notes to the Financial Statements

for the Period Ended 29 September 2024

2. Employees

2024 2023
Average number of employees during the period 0 0

MED MATTERS LTD

Notes to the Financial Statements

for the Period Ended 29 September 2024

3. Tangible Assets

Total
Cost £
At 30 September 2023 89,633
At 29 September 2024 89,633
Depreciation
At 30 September 2023 10,263
Charge for year 12,350
At 29 September 2024 22,613
Net book value
At 29 September 2024 67,020
At 29 September 2023 79,370

MED MATTERS LTD

Notes to the Financial Statements

for the Period Ended 29 September 2024

4. Loans to directors

Name of director receiving advance or credit: Ross Tyler Burgess
Description of the loan: Med Matters have receivable of £489,605 from Mr. Ross Tyler Burgess for the year ended 29 Sep 2024
£
Balance at 30 September 2023 477,188
Advances or credits made: 12,417
Balance at 29 September 2024 489,605